Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

A man living with advanced liver cancer has seen his tumour shrink by over half as “exciting” new clinical trials are ...

Worldwide, hepatitis B virus is the major risk factor for hepatocellular carcinoma (HCC), owing to ... surveillance regimes of α-fetoprotein and ultrasound may be augmented by novel biomarkers ...

Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...

Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...

CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...

Key search terms included Hepatocellular carcinoma, HCC, Liver cancer, Magnetic resonance imaging, MRI, radiomics, deep learning, machine learning, and artificial intelligence. Results: A ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Variations in tumor biology from patient to patient combined with the low overall survival rate of hepatocellular carcinoma ... HCC is diagnosed based on imaging and laboratory criteria, making it the ...